Organon & Co.
OGN· NYSE
OGNOrganon & Co.
Quarterly figures for Organon & Co., with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Organon & Co. has filed its 10-Q within 31 to 41 days of period end across its last 8 quarters. The 10-K runs 55 to 80 days.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Jul 31, 2026 | 31 d | 10-Q | $1.56B | −2.3% | $0.40 | |
| Mar 31, 2026 |
| Apr 30, 2026 · pre-market |
| May 4, 2026 |
| 34 d |
| 10-Q |
| $1.46B |
| −3.5% |
| $0.55 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 12, 2026 · pre-market | Feb 24, 2026 | 55 d | 10-K | $1.51B | −5.3% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · pre-market | Nov 10, 2025 | 41 d | 10-Q | $1.60B | +1.3% | $0.61 | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · pre-market | Aug 6, 2025 | 37 d | 10-Q | $1.59B | −0.8% | $0.56 | |
| Q1 2025 | Mar 31, 2025 | May 1, 2025 · pre-market | May 2, 2025 | 32 d | 10-Q | $1.51B | −6.7% | $0.33 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 13, 2025 · pre-market | Feb 28, 2025 | 59 d | 10-K | $1.59B | −0.4% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 31, 2024 · pre-market | Nov 1, 2024 | 32 d | 10-Q | $1.58B | +4.1% | $1.38 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · pre-market | Aug 7, 2024 | 38 d | 10-Q | $1.61B | −0.1% | $0.75 | |
| Q1 2024 | Mar 31, 2024 | May 2, 2024 · pre-market | May 3, 2024 | 33 d | 10-Q | $1.62B | +5.5% | $0.78 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 15, 2024 · pre-market | Feb 26, 2024 | 57 d | 10-K | $1.60B | +7.6% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 2, 2023 · pre-market | Nov 3, 2023 | 34 d | 10-Q | $1.52B | −1.2% | $0.23 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · pre-market | Aug 9, 2023 | 40 d | 10-Q | $1.61B | +1.5% | $0.95 | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · pre-market | May 5, 2023 | 35 d | 10-Q | $1.54B | −1.9% | $0.69 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 16, 2023 · pre-market | Feb 27, 2023 | 58 d | 10-K | $1.49B | −7.4% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 3, 2022 · pre-market | Nov 4, 2022 | 35 d | 10-Q | $1.54B | −3.9% | $0.89 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · pre-market | Aug 5, 2022 | 36 d | 10-Q | $1.59B | −0.6% | $0.92 | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · market hours | May 6, 2022 | 36 d | 10-Q | $1.57B | +4.1% | $1.36 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 17, 2022 · pre-market | Mar 21, 2022 | 80 d | 10-K | $1.60B | −0.6% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | $1.60B | −0.8% | $1.27 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $1.60B | +4.5% | $1.68 | |
| Q1 2021 | Mar 31, 2021 | — | Jun 21, 2021 | 82 d | 10-Q | $1.51B | −15.4% | $1.58 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | $1.61B | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $1.61B | — | $2.16 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $1.53B | — | $2.14 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $1.78B | — | $2.78 | |
